WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998048840) POLYETHYLENE GLYCOL-INTERFERON ALPHA CONJUGATES FOR THERAPY OF INFECTION
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/1998/048840 International Application No.: PCT/US1998/007634
Publication Date: 05.11.1998 International Filing Date: 28.04.1998
Chapter 2 Demand Filed: 09.11.1998
IPC:
A61K 47/48 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
48
the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Applicants: SCHERING CORPORATION[US/US]; 2000 Galloping Hill Road Kenilworth, NJ 07033-0530, US
Inventors: GLUE, Paul; US
CUTLER, David, L.; US
AFFRIME, Melton, B.; US
Agent: McLAUGHLIN, Jaye, P. ; Schering-Plough Corporation Patent Dept., K-6-1 1990 2000 Galloping Hill Road Kenilworth, NJ 07033-0530, US
Priority Data:
08/839,10129.04.1997US
Title (EN) POLYETHYLENE GLYCOL-INTERFERON ALPHA CONJUGATES FOR THERAPY OF INFECTION
(FR) CONJUGUES POLYETHYLENEGLYCOL-INTERFERON ALPHA, POUR LA THERAPIE DES INFECTIONS
Abstract:
(EN) A method comprising administering a PEG12000-IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.
(FR) Cette invention se rapporte à un procédé consistant à administrer un conjugué PEG12000-IFN alpha à un individu souffrant d'une infection virale susceptible d'être traitée avec de l'interféron alpha, cette infection étant de préférence l'hépatite C chronique.
Designated States: AL, AM, AU, AZ, BA, BB, BG, BR, BY, CA, CN, CZ, EE, GE, GW, HU, ID, IL, IS, JP, KG, KR, KZ, LC, LK, LR, LT, LV, MD, MG, MK, MN, MX, NO, NZ, PL, RO, RU, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UZ, VN, YU
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)